| John C Vandree, MD | |
|
1330 Rockefeller Ave, Suite 340, Everett, WA 98201-1684 | |
| (425) 252-1116 | |
| Not Available |
| Full Name | John C Vandree |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1330 Rockefeller Ave, Everett, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558317123 | NPI | - | NPPES |
| 1264100 | Medicaid | WA | |
| 0037225 | Other | WA | LABOR AND INDUSTRY |
| MD00015984 | Other | WA | STATE LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD00015984 (Washington) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD00015984 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John C Vandree, MD 1330 Rockefeller Ave, Suite 340, Everett, WA 98201-1684 Ph: (425) 252-1116 | John C Vandree, MD 1330 Rockefeller Ave, Suite 340, Everett, WA 98201-1684 Ph: (425) 252-1116 |
News Archive
A provision of U.S. law that bans HIV-positive foreigners from entering the country is harming testing efforts and excluding eligible candidates for citizenship, according to members of a panel held by the Global Health Council on Nov. 15, CQ HealthBeat reports.
New research indicates that transgender and non-binary individuals are significantly more likely to have autism or display autistic traits than the wider population - a finding that has important implications for gender confirmation treatments.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.
Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease (IPD) are down significantly in all age groups, while rates of IPD caused by non-vaccine strains are modestly on the rise.
Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.
› Verified 8 days ago
Timothy Edward Mcnamara, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1001 N Broadway, Suite A3, Everett, WA 98201 Phone: 425-317-0300 Fax: 425-317-0303 | |
Dr. Madhurina Roy, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9505 19th Ave Se, Ste 100, Everett, WA 98208 Phone: 425-225-6721 Fax: 425-225-6725 | |
Dr. Kavyashri Kodlipet Jagadeesh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave Ste 210, Everett, WA 98201 Phone: 425-261-4940 Fax: 425-261-4932 | |
Amy D Nelson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2930 Maple St, Everett, WA 98201 Phone: 425-261-1500 Fax: 425-261-1515 | |
Ya-lan Huang, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave, Suite 450, Everett, WA 98201 Phone: 425-258-6801 | |
Mahesh Mulumudi, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5411 | |
James M Schmitt, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 12728 19th Ave Se, Suite 200, Everett, WA 98208 Phone: 425-225-2700 Fax: 425-225-2790 |